Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
investorplace.com/2024/05/novavax-sheds-going-concern-warning-as-nvax-stock-pops-on-sanofi-licensing-deal
Novavax (NASDAQ:NVAX) stock has more than doubled today and is up more than 120% at the time of this writing. This morning, the company announced a co-exclusive licensing agreement with Sanofi (NASDAQ:SNY) to commercialize its Covid-19 vaccine. The agreement will also provide Sanofi with a sole license to the vaccine for use in combination with its flu vaccines.
On top of…
This story appeared on investorplace.com, .